Thanakit Suebsaicharoen

[Thanakit Suebsaicharoen @thanakitsueb]

Delighted to share my recent publication in @Open_HeartBMJ on comparative cardiovascular outcomes of #HFrEF GDMT treatments.

https://t.co/6i0b0AvHkB

#HeartFailure #CardioTwitter #MedTwitter

[The Heart @ZHeart11768530]

🔴Beyond quadruple therapy: #2024Review
🔹The potential roles for ivabradine, vericiguat, and omecamtiv mecarbil in the therapeutic armamentarium

🔹https://t.co/UgKYoI33A2
#MedEd #Cardiology #MedX #paramedicstudent #cardiovascular #cardiotwiteros #CardioEd #CardioTwitter

[Thanakit Suebsaicharoen @thanakitsueb]

Do you remember when you joined X? I do! #MyXAnniversary

[Iris Blom @blom_iris]

"When health is at risk, everything is at risk"

✨ The @WHO Investment Round is launched by @DrTedros - with the aim to transform how the WHO is financed and, in turn, transform the organization: for flexible, predictable and resilient funding.

#InvestInWHO #HealthForAll #WHA77

[JACC Journals @JACCJournals]

New leading edge commentary now in #JACCHF by Drs. @lamcardio and @pmyhre on #ARNI implementation across the spectrum of #heartfailure.

Excellent primer on ARNI efficacy in chronic and subacute #HFrEF and #HFpEF, stage B+D HF. https://t.co/GNtcAE4MIn

[JACC Journals @JACCJournals]

See the pooled results of PIONEER-HF and PARAGLIDE-HF trial assessing safety and efficacy of sacubitril/valsartan following a worsening HF event across the spectrum of EF. https://t.co/9UK0Evecem

#JACC #HeartFailure #LVEF @robmentz @ShelleyZieroth @KSharmaMD @scottdsolomon

[Pradeep Natarajan @pnatarajanmd]

One of the most important cardiology papers, updated annually - 2024 @American_Heart Heart Disease and Stroke Statistics Update.
Congrats/thanks to all authors - esp our very own @MGHCVFellows @tigerstatdoc!
https://t.co/kjua99NKXn @CircAHA @AHAScience

[Thanakit Suebsaicharoen @thanakitsueb]

Thank you @AHAScience

[AHA Science @AHAScience]

#TBT to our Paul Dudley White International Scholar Award winners announced during #AHA23!

This award recognizes the team of authors with the highest-ranked scientific abstract from every participating country - this year we had a total of 60 countries!

[Thanakit Suebsaicharoen @thanakitsueb]

@TChaikijurajai @SalinAmpn @MayoCVFellows @MayoClinicCV @Taopitchaya @umnmedresidency @TheNRMP Congratulations krub!

[Thanakit Suebsaicharoen @thanakitsueb]

We are honoured to be recognised along with our peers at #AHA23 for the highest ranked abstract submitted from Thailand. @AHAScience @American_Heart

[Open Heart @Open_HeartBMJ]

Comparative cardiovascular outcomes of novel drugs as an addition to conventional triple therapy for heart failure with reduced ejection fraction (HFrEF): a network meta-analysis of randomised controlled trials
https://t.co/7e6spCm4yo

[AHA Science @AHAScience]

🧵/ Late breaking science results from #AHA23 will be posted to this thread at the time of presentation:

SELECT
MINT
ORBITA-2
CRHCP Dementia
POP-HT
KARDIA-1
CARDIA-SSBP
ARTESIA
VERVE-101
ESPRIT
SPEC-AI Nigeria
SPEECH

⬇️

(bookmark this post)

[Thanakit Suebsaicharoen @thanakitsueb]

On the first day of #AHA23, we got a great opportunity to learn from many professors and colleagues who came to visit our posters. We will surely bring back comments and suggestions to improve our study.

[Thanakit Suebsaicharoen @thanakitsueb]

We are here in Philly and excited to present our poster abstracts on #InterventionalCardiology at #AHA23 tomorrow.

[Thanakit Suebsaicharoen @thanakitsueb]

Our findings suggest that SGLT2i addition to the conventional triple therapy of ACEI+BB+MRA or ACEI replacement with ARNI could prolong median time to develop cardiovascular death or heart failure hospitalisation, with the median times of longer than 57.7 months.

[Thanakit Suebsaicharoen @thanakitsueb]

Delighted to share my recent publication in @Open_HeartBMJ on comparative cardiovascular outcomes of #HFrEF GDMT treatments.

https://t.co/6i0b0AvHkB

#HeartFailure #CardioTwitter #MedTwitter

[American Heart Association @American_Heart]

Someone may be waiting for you ... to save a life with Hands-Only CPR. If you see a teen or adult collapse, call 911 and push hard & fast in the center of the chest at a rate of 100-120 beats per minute.

Welcome to the #NationofLifesavers. @taylorswift13 #1989TaylorsVersion

[Thanakit Suebsaicharoen @thanakitsueb]

Honoured to be awarded Paul Dudley White International Scholar Award from @American_Heart @AHAScience for my abstract submitted to #AHA23
#CardioTwitter #MedTwitter

[The Modern Surgeon @modern_surgeon]

Every medical student realizes their first time in the OR that they have another unspoken responsibility:

Being a camera person.

Here's a short thread about your new equipment🧵

[Thanakit Suebsaicharoen @thanakitsueb]

Delighted to have two of my abstracts on interventional cardiology 🫀 accepted for AHA 2023! #AHA23 #CardioTwitter

[Abdulla A. Damluji, MD, PhD @DrDamluji]

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: @JACCJournals

* I am reading this slowly; only way to read these thick documents: On goals of treatment and shared decision making!

🥸 Thread #3

👇👇👇